Safety Study of Minimally Invasive Approaches to Unruptured Anterior Circulation Aneurysms (MININCRUSP)
Cerebral Aneurysm, Aneurysm, Middle Cerebral Artery, Aneurysm, Anterior Communicating Artery
About this trial
This is an interventional treatment trial for Cerebral Aneurysm focused on measuring Brain Aneurysm, Pterional Craniotomy, MiniPterional Craniotomy, Transpalpebral Approach, Unruptured Brain Aneurysm
Eligibility Criteria
Inclusion Criteria:
- Patients with the diagnosis of incidental unruptured cerebral aneurysms (4mm to 2cm)
Exclusion Criteria:
- Patients who do not have adequate family care during the immediate post-operative period (the patient's family must commit to stay with the patient in the first five days after hospital discharge)
- Patients who are unable to communicate by telephone
- People with cardiovascular disease, liver or kidney failure.
- Pregnant women or breastfeeding
- Patients with coagulation abnormalities
- Patients with High Surgical Risk evaluated by different risk scores (ASA, AHA, Goldman, Detsky)
Sites / Locations
- Hospital das Clínicas of University of São Paulo Medical SchoolRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Experimental
Sham Comparator
Transpalpebral Approach
NanoPterional Approach
Classical Pterional Craniotomy
Aneurysm Clipping - Patients will be submitted to a Transpalpebral Approach to Unruptured Anterior Circulation Aneurysm and they will be discharged from the hospital on the next day.
Aneurysm Clipping - Patients will be submitted to a Modified MiniPterional Approach (Nanopterional) to Unruptured Anterior Circulation Aneurysm and they will be discharged from the hospital on the next day.
Aneurysm Clipping - Patients will be submitted to a Classical Pterional Approach to Unruptured Anterior Circulation Aneurysm and they will be discharged from the hospital 4-5 days after the procedure.